Mesoblast (ASX:MSB) share price soars 14% on clinical trial results
The Mesoblast share price soared today as the company announced positive clinical trial results. We take a closer look.
Full Article
Mesoblast (ASX:MSB) share price soars 14% on clinical trial results
Motley Fool
0 shares
1 views
You might like
Related news coverage
NA Proactive news snapshot: PyroGenesis, Water Tower Research, Viscount Mining, True Leaf Brands, Kintara Therapeutics, HempFusion Wellness UPDATE ...
PyroGenesis Canada Inc (TSE:PYR) (OTCQB:NYRNF) CEO Peter Pascali will present at the SNN Network Canada virtual event on Thursday..
Proactive Investors